Pancreatic Tumor Vanishes Using Immune-Drug Combo Therapy
A Breakthrough in Pancreatic Cancer Treatment Patients suffering from severe cancer often turn to large hospitals in Seoul for treatment. However, recent developments have shown that regional hub hospitals are also achieving remarkable results. One such case involves a 53-year-old woman who successfully underwent treatment for metastatic stage 4 pancreatic cancer at a regional hospital. Professor Choi Jong-kwon, from the Department of Hematology-Oncology at Konyang University Hospital, shared the findings of a study involving this patient. The case highlights the potential of combining traditional anticancer therapies with innovative immune cell treatments. The patient was diagnosed with stage 4 pancreatic cancer, which means the disease had already spread to other parts of the body, making surgery an impossible option. Pancreatic cancer is known for being one of the most challenging cancers to treat, with the lowest survival rate among all types of cancer. In advanced stages, the c...